Source: Annual Congress 2001 - Updates of asthma therapy in children
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Stelmach, J. Jerzynska, M. Bobrowska, P. Kuna (Zgierz, Lodz, Poland). The effect of montelukast and triamcinolon on clinical parameters and serum levels of ECP, sIL-2R and IL-4 in children with moderate asthma. Eur Respir J 2001; 16: Suppl. 31, 841

Member's Comments

No comment yet.

Related content which might interest you: The effect of nedocromil and montelukast on IL-10 serum level in children with moderate asthma Source: Eur Respir J 2001; 18: Suppl. 33, 123s Year: 2001 Effect of montelukast administration on serum IL-5 and total IgE levels in asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 579s Year: 2004 IL-4, IFN-gamma and TNF-alpha levels in serum of patients with COPD, bronchial asthma and GERD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 Elevated serum IL-12 and IL-18 levels in patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 424s Year: 2002 Serum TNF-a, IL-12 and IL-13 levels in severe bronchial asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 353s Year: 2004 Serum levels of IL-8, IL-10 and TNFα in severe allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005 Serum level of soluble interleukin-2 receptors (sIL-2R) during acute asthma exacerbation, and its relation to severity and response to bronchodilator therapy Source: Eur Respir J 2002; 20: Suppl. 38, 141s Year: 2002 One year monitoring of children with bronchial asthma and other allergic diseases treated with inhaled corticosteroids vs cromoglycates with serum ECP (S-ECP), FEV1, total IgE and blood eosinophil count - the influence of different therapy Source: Eur Respir J 2002; 20: Suppl. 38, 432s Year: 2002 The effects of inhaled steroids, leukotriene receptor antagonists and theophylline on induced sputum cell counts, serum and sputum ECP levels in mild persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001 Serum levels of IL-5, IL-6 and IL-8 in moderate and severe asthma clusters Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Values of systemic ECP, IL-4 and IL-5 in asthmatic patients Source: Eur Respir J 2004; 24: Suppl. 48, 353s Year: 2004 Interleukin-10 (IL-10) level in sputum of asthmatic patients during exacerbation and after treatment Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001 The role of ECP, IL-4 and IL-5 in asthmatic patients Source: Eur Respir J 2003; 22: Suppl. 45, 292s Year: 2003 Plasma eotaxin level in children with acute bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 314s Year: 2003 Serum levels of IL-6 in adult patients with moderate to severe asthma. Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017 LSC - 2019 - IL-4, IL-8, IL-13, IL-17, IL-33 serum levels changes in acute allergic asthma model Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019 Interaction between eotaxin and IL-13 in serum and sputum: comparison between normal and allergic asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 396s Year: 2004 Serum IL-12p70 and IL-12p40 levels in severe asthma patients with fixed airway obstruction Source: Eur Respir J 2006; 28: Suppl. 50, 234s Year: 2006 Ciclesonide 80 μg once daily reduces early and late asthmatic reaction, sputum eosinophils and serum ECP in asthma patients challenged with allergens Source: Eur Respir J 2005; 26: Suppl. 49, 254s Year: 2005 IL-13 polymorphism R130Q and total serum IgE levels in children with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 524s Year: 2002